Clinicopathologic manifestations of early-onset endometrial cancer in Japanese women with a familial predisposition to cancer

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 5, 2005, Pages 444-451

  Yamagami, Wataru ^a   Susumu, Nobuyuki ^a   Banno, Kouji ^a   Hirao, Takeshi ^a   Kataoka, Fumio ^a   Hirasawa, Akira ^a   Suzuki, Nao ^a   Aoki, Daisuke ^a   Nozawa, Shiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial cancer; Family history of cancer; HNPCC; Obesity

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM CARCINOMA; FAMILY HISTORY; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; JAPAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NULLIPARA; OBESITY; ONSET AGE; PHYSICAL EXAMINATION; PROGNOSIS; SURVIVAL RATE; TRANSVAGINAL ECHOGRAPHY;

ADENOCARCINOMA; ADULT; AGE OF ONSET; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN;

EID: 27744586345     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00318.x     Document Type: Article

References (34)

1. Udagawa Y, Nikata M, Nozawa S. Familial history of endometrial cancer. In: Kuramoto H (ed.). Comprehensive Handbook of Women's Medicine No. 35. Tokyo: Nakayama Bookstore, 2001; 278-288 (in Japanese).
2. Udagawa Y, Miyashita A, Nozawa S. Clinical features and treatment of endometrial adenocarcinoma in young women. Karkinos 1993; 6: 735-738 (in Japanese).
3. Susumu N, Aoki D, Suzuki N, Nozawa S. Hormonal therapy for endometrial adenocarcinoma. Jpn J Cancer Chemother 2001; 28: 934-945 (in Japanese).
4. Lynch HT, Krush AT, Larsen AL, Magnuson CW. Endometrial carcinoma; Multiple primary malignancies, constitutional factors, and heredity. Am J Med Sci 1996; 252: 381-403.
5. Berends MJW, Kleibeuker JH, de Vries EGE et al. The importance of family history in young patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol 1992; 82: 139-141.
6. Ito K, Sasano M, Sato S. Endometrial cancer in young women. In: Kuramoto H (ed.). Comprehensive Handbook of Women's Medicine No. 35. Tokyo: Nakayama Bookstore, 2001; 251-263 (in Japanese).
7. Niwa K, Imai A, Hashimoto M et al. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep 2000; 7: 89-93.
8. Tran BN, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 2000; 23: 476-480.
9. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998; 91: 349-354.
10. Jobo T, Ookawara S, Tsuchiya G, Kuramoto H, Arai M. Clinicopathological analysis of endometrial carcinoma in young women. J Jpn Soc Cancer Ther 1989; 24: 2362-2368 (in Japanese).
11. Aziz H, Hussain F, Edelman S et al. Age and race as prognostic factors in endometrial carcinoma. Am J Clin Oncol 1996; 19: 595-600.
12. Parslov M, Lidegaard O, Kintorp S et al. Risk factors among young women with endometrial cancer: A Danish case-control study. Am J Obstet Gynecol 2000; 182: 23-29.
13. Henderson BE, Casagrande JT, Pike MC, Rosario I, Duke A. The epidemiology of endometrial cancer in young women. Br J Cancer 1983; 47: 749-756.
14. Salha O, Martin-Hirsch P, Lane G, Sharma V. Endometrial carcinoma in a young patient with polycystic ovarian syndrome: First suspected at time of embryo transfer. Hum Reprod 1997; 12: 959-962.
15. Susumu N. The reference of new molecular cellular biological prognostic factor and the significance for normalizing the treatment. Acta Obst Gynaec Jpn 2005; 57: 374-375.
16. Vinker S, Shani A, Open M, Fenig E, Dgani R. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? Eur J Obstet Gynecol Reprod Biol 1999; 83: 63-65.
17. Kaku T, Yoshikawa H, Tsuda H et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: Central pathologic review and treatment outcome. Cancer Lett 2001; 167: 39-48.
18. Nikata M, Udagawa Y, Nozawa S. Hereditary nonpolyposis colorectal cancer (HNPCC) and gynecological cancer. In: Kuramoto H (ed.). Comprehensive Handbook of Women's Medicine No. 35. Tokyo: Nakayama Bookstore, 2001; 278-288 (in Japanese).
19. Banno K, Susumu N, Hirao T et al. Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 2003; 146: 58-65.
20. Wijnen J, de Leeuw W, Vansen H et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nature Genet 1999; 23: 142-144.
21. Knab DR. Estrogen and endometrial carcinoma. Obstet Gynecol Surv 1997; 32: 267-281.
22. Bokhman JV. Two pathogenic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-17.
23. Planck M, Rambech E, Moslein G, Muller W, Oisson H, Nibert M. High frequency of microsatellite instability and loss of mismatch-repair protein in patients with double primary tumors of the endometrium and colorectum. Cancer 2000; 94: 2502-2510.
24. Caldes T, Godino J, de la Hoya M et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer 2002; 98: 774-779.
25. Parc YR, Halling KC, Burgart LJ et al. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology. Int J Cancer 2000; 86: 60-66.
26. Vasen H, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
27. Ballard-Barbach R, Swanson CA. Body weight: Estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996; 63: 437S-441S.
28. Dahlgren E, Friberg LG, Johansson S et al. Endometrial carcinoma; ovarian dysfunction - a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 1991; 41: 143-150.
29. Hata H, Kuramoto H. Etiology and pathology. In: Kuramoto H (ed.). Comprehensive Handbook of Women's Medicine No. 35. Tokyo: Nakayama Bookstore, 2001; 61-71 (in Japanese).
30. Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996; 148: 1671-1678.
31. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas: Frequent replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-156.
32. Takemoto N, Konishi F, Yamashita K et al. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: The significance of different types of lymphocyte infiltration. Jpn J Clin Oncol 2004; 34: 90-98.
33. Phillip SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 2004; 91: 469-475.
34. Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB. Intratumoral CD8+ T Lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10: 4450-4456.